Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma

NCT00365560 ·Status: COMPLETED ·Phase: PHASE2

TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)

NCT02676089 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

NCT01277523 ·Status: COMPLETED ·Phase: PHASE3

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

NCT00255255 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

NCT01577953 ·Status: COMPLETED ·Phase: PHASE1

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

NCT01581177 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma

NCT01122680 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma

NCT02281357 ·Status: COMPLETED ·Phase: PHASE3

TC-6987 for the Treatment of Mild to Moderate Asthma

NCT01296087 ·Status: COMPLETED ·Phase: PHASE2

Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response

NCT04150341 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

NCT00116103 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

NCT01556607 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

NCT00837967 ·Status: COMPLETED ·Phase: PHASE3

Impact of Tiotropium Add-on Therapy in Patients With Asthma

NCT03964220 ·Status: COMPLETED

Selective β2-AR Antagonism in Asthma

NCT07272135 ·Status: COMPLETED ·Phase: PHASE1

Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3

NCT02322788 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

NCT01634113 ·Status: COMPLETED ·Phase: PHASE2

Single and Multiple Ascending Dose Study of KN-002

NCT05006521 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

NCT01696071 ·Status: COMPLETED ·Phase: PHASE2

To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study

NCT01096017 ·Status: COMPLETED ·Phase: PHASE3

Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients

NCT00252785 ·Status: COMPLETED ·Phase: PHASE3

Trial of Simvastatin for the Treatment of Severe Asthma

NCT02433535 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma

NCT00822861 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma

NCT01383499 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

NCT01634152 ·Status: COMPLETED ·Phase: PHASE3